NDC 0143-9575-01 - Lidocaine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0143-9575
- Requested NDC
- 0143-9575-01
- Package NDCs from labels
- 0143-9575-01, 0143-9575-10
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2025-10-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lidocaine - A-S Medication Solutions | A-S Medication Solutions | 2025-10-21 | HUMAN PRESCRIPTION DRUG LABEL |
| LIDOCAINE HCI - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2025-07-09 | HUMAN PRESCRIPTION DRUG LABEL |
| Lidocaine - Hikma Pharmaceuticals USA Inc. | Hikma Pharmaceuticals USA Inc. | 2025-05-01 | HUMAN PRESCRIPTION DRUG LABEL |
| Lidocaine - Medical Purchasing Solutions, LLC | Medical Purchasing Solutions, LLC | 2023-05-16 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0143-9575-01 | Lidocaine | 50 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 50 | 6 | |
| 0143-9575-10 | Lidocaine | 10 in 1 PACKAGE | INJECTION, SOLUTION | 10 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0143-9575 | LIDOCAINE (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION LIDOCAINE (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HIKMA PHARMACEUTICALS USA INC.] | 5 | Current NDC, Legacy NDC, 2 package rows | 20250521_5523fdfe-69fd-49a5-b51f-73e2223d49a9.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0143-9575-01 | ML - Milliliter | 0143-9575 | e0e5c666-8931-44d8-b700-5faf7af18880 | 1 | 2017-10-13 |
| 0143-9575-10 | ML - Milliliter | 0143-9575 | 23cc4249-984a-418e-a4b5-e58307ead774 | 1 | 2017-10-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| EVERLIT CARE PRODUCTS BURN RELIEF | LIDOCAINE HYDROCHLORIDE | EVERLIT GLOBAL INC. | d7ec5720-4d1f-4943-ae36-c7d6acbae7d7 | 2026-05-04 | Warnings | V13007Z41A |
| EVERLIT CARE PRODUCTS BURN RELIEF | LIDOCAINE HYDROCHLORIDE | Nantong Health & Beyond Hygienic Products Inc. | 5371dae4-ea63-46cc-ac26-5418f359c63e | 2026-05-04 | Warnings | V13007Z41A |
| EVERLIT CARE BURN | LIDOCAINE HYDROCHLORIDE, BENZALKONIUM CHLORIDE | Nantong Health & Beyond Hygienic Products Inc. | a2cf1726-3dc9-4624-b898-ac91fb4cbdb2 | 2026-05-04 | Warnings | V13007Z41A |
| FIRSTAR BURN | LIDOCAINE HYDROCHLORIDE | Nantong Health & Beyond Hygienic Products Inc. | 186343c5-2e71-49c4-8d64-5fb3131239fa | 2026-05-04 | Warnings | V13007Z41A |
| FIRST AID BURN | LIDOCAINE HYDROCHLORIDE,BENZALKONIUM CHLORIDE | 4 Visions LLC | 50b1351d-72dd-e0c9-e063-6294a90ac743 | 2026-04-30 | Warnings | V13007Z41A |
| Sodium Chloride | SODIUM CHLORIDE | Sportpharm LLC | a2c111f6-74d5-4a5d-82ac-d0f237488cb8 | 2026-04-24 | Warnings, Adverse reactions | 451W47IQ8X |
| Lidocaine | LIDOCAINE HYDROCHLORIDE | Sportpharm LLC | cffda6fc-7e85-4c48-9623-2551d3552d7d | 2026-04-24 | Warnings, Adverse reactions | 1010033 V13007Z41A |
| Sodium Chloride | SODIUM CHLORIDE | Method Pharmaceuticals, LLC | 4b08859e-65bd-8255-e063-6394a90af614 | 2026-04-23 | Warnings | 451W47IQ8X |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Bryant Ranch Prepack | 850bdb6a-85d9-441d-8666-7a61311386b6 | 2026-04-23 | Warnings, Adverse reactions | V13007Z41A |
| LIDOCAINE | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Henry Schein Inc. | 1ca96c77-d983-496b-84a6-54709e80f532 | 2026-04-23 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Henry Schein Inc. | f8d90500-f797-4238-8dd2-b59cbcd89d12 | 2026-04-23 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride and Epinephrine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | Sportpharm LLC | 2c58deba-dbb2-4e73-a173-36053536f03e | 2026-04-22 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine | LIDOCAINE HYDROCHLORIDE | Sportpharm LLC | 7adb9ab0-ef91-4c51-baa3-a0b7e12df077 | 2026-04-21 | Warnings, Adverse reactions | ANDA080407 1010033 V13007Z41A |
| LIDOCAINE HYDROCHLORIDE | LIDOCAINE HYDROCHLORIDE | Bryant Ranch Prepack | 8f79b023-9bd1-4bd6-8fd0-f9efe88abec0 | 2026-04-20 | Warnings, Adverse reactions | V13007Z41A |
| Ringers | SODIUM CHLORIDE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE | ICU Medical, Inc. | a926f913-18fa-4a3e-bfd6-210e1e427960 | 2026-04-20 | Warnings, Adverse reactions | 451W47IQ8X |
| Cardioforce II | ABROTANUM, BOLDO, CIMICIFUGA RACEMOSA, KALI PHOSPHORICUM, TARAXACUM OFFICINALE, CONVALLARIA MAJALIS, MAGNESIA SULPHURICA, OLEANDER, NATRUM MURIATICUM, BELLIS PERENNIS | BioActive Nutritional, Inc. | 733bbb26-7698-4a1b-9dc8-7e3490ffc92b | 2026-04-17 | Warnings | 451W47IQ8X |
| Thyroid HP | BARYTA CARBONICA, CALCAREA CARBONICA, FUCUS VESICULOSUS, IODIUM, NATRUM MURIATICUM, PULSATILLA, SPONGIA TOSTA, THYROIDINUM (SUIS) | BioActive Nutritional, Inc. | 3795820a-cf2a-4094-9a02-70e3757b7510 | 2026-04-17 | Warnings | 451W47IQ8X |
| DIANEAL Low Calcium with Dextrose | SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE | Vantive US Healthcare LLC | aa268d3f-7389-4f25-801f-5d4825495f08 | 2026-04-16 | Warnings, Adverse reactions | 451W47IQ8X |
| Burn Cream | BENZALKONIUM CHLORIDE, LIDOCAINE HCI | Prostat First Aid | 4f9adbac-5497-e7be-e063-6294a90a7518 | 2026-04-16 | Warnings | V13007Z41A |
| Lidoease 2% | LIDOCAINE HCL 2% | PureTek Corporation | 3ba0c0ff-0f7a-7a29-e063-6294a90a547a | 2026-04-16 | Warnings | V13007Z41A |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.